SCHEMBL4041150

SCHEMBL4041150

c1cnc2[nH]c(-c3ccsc3)nc2n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.50
CDK5 Q00535 2/20 0.50
CDK5R1 Q15078 2/20 0.50
CCNB2 O95067 1/20 0.50
CDK1 P06493 1/20 0.50
CCNB1 P14635 1/20 0.50
CCNB3 Q8WWL7 1/20 0.50
METAP2 P50579 1/20 0.49
METAP1 P53582 1/20 0.49
CYP2A6 P11509 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2B6 P20813 1/20 0.39
CYP2C19 P33261 1/20 0.39
GSK3A P49840 1/20 0.39
WNT3A P56704 1/20 0.38
TNKS2 Q9H2K2 1/20 0.38
LRRK2 Q5S007 1/20 0.37
WNT1 P04628 1/20 0.36
GRM4 Q14833 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4046146 0.75 METAP2 (0.64) GSK3BCDK5CDK5R1CCNB2CDK1
SCHEMBL4153600 0.75 CLK2 (0.43) GSK3BCDK5CDK5R1CCNB2CDK1
SCHEMBL10737047 0.72 METAP2 (0.51) GSK3BMETAP2METAP1
SCHEMBL10735823 0.72 METAP2 (0.51) GSK3BCDK5CDK5R1CCNB2CDK1
SCHEMBL4161109 0.71 DHODH (0.50) GSK3BCDK5CDK5R1CCNB2CDK1
SCHEMBL10742407 0.69 CCNB2 (0.51) GSK3BCCNB2CDK1CCNB1CCNB3
SCHEMBL10743109 0.69 METAP2 (0.47) GSK3BMETAP2METAP1GSK3A
SCHEMBL10738052 0.69 AURKA (0.64) GSK3BCDK5CDK5R1CCNB2CDK1
SCHEMBL10735517 0.69 AURKA (0.64) GSK3BCCNB2CDK1CCNB1CCNB3
SCHEMBL4158223 0.68 PKN1 (0.49) GSK3BCDK5CDK5R1CCNB2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546150-B1 PYRROLE DERIVATIVES AS INHIBITORS OF CYTEINE PROTEASES AMURA THERAPEUTICS LTD (GB) 2009-03-04 EP claimed
WO-2009029592-A1 HETEROBICYCLIC-SUBSTITUTED QUINOLONES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS KALYPSYS, INC. (US) 2009-03-05 WO disclosed
WO-2009029592-A1 HETEROBICYCLIC-SUBSTITUTED QUINOLONES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS KALYPSYS, INC. (US) 2009-03-05 WO disclosed